Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial

微卫星不稳定性 医学 福尔菲里 内科学 克拉斯 结直肠癌 氟尿嘧啶 胃肠病学 危险系数 阶段(地层学) 肿瘤科 癌症 微卫星 伊立替康 等位基因 置信区间 生物 古生物学 生物化学 基因
作者
Dirk Klingbiel,Zacharenia Saridaki,A. Roth,Fred T. Bosman,Mauro Delorenzi,Sabine Tejpar
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:26 (1): 126-132 被引量:203
标识
DOI:10.1093/annonc/mdu499
摘要

BackgroundAlthough colon cancer (CC) with microsatellite instability (MSI) has a more favorable prognosis than microsatellite stable (MSS) CC, the impact varies according to clinicopathological parameters. We studied how MSI status affects prognosis in a trial-based cohort of stage II and III CC patients treated with 5-fluorouracil (5-FU)/leucovorin or FOLFIRI.Materials and methodsTissue specimens of 1254 patients were tested for 10 different loci and were classified as MSI-high (MSI-H) when three or more loci were unstable and MSS otherwise. Study end points were overall survival (OS) and relapse-free survival (RFS).ResultsIn stage II, RFS and OS were better for patients with MSI-H than with MSS CC [hazard ratio (HR) 0.26, 95% CI 0.10–0.65, P = 0.004 and 0.16, 95% CI 0.04–0.64, P = 0.01). In stage III, RFS was slightly better for patients with MSI-H CC (HR 0.67, 95% CI 0.46–0.99, P = 0.04), but the difference was not statistically significant for OS (HR 0.70, 95% CI 0.44–1.09, P = 0.11). Outcomes for patients with MSI-H CC were not different between the two treatment arms. RFS was better for patients with MSI-H than with MSS CC in the right and left colon, whereas for OS this was significant only in the right colon. For patients with KRAS- and BRAF-mutated CC, but not for double wild-type patients, RFS and OS were significantly better when the tumors were also MSI-H. An interaction test was statistically significant for KRAS and MSI status (P = 0.005), but not for BRAF status (P = 0.14).ConclusionsOur results confirm that for patients with stage II CC but less so for those with stage III MSI-H is strongly prognostic for RFS and OS. In the presence of 5-FU treatment, stage II patients with MSI-H tumors maintain their survival advantage in comparison with MSS patients and adding irinotecan has no added benefit.ClinicalTrials.gov IdentifierNCT00026273.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
凶狠的八宝粥完成签到,获得积分10
刚刚
刚刚
theverve发布了新的文献求助10
1秒前
浮浮完成签到,获得积分10
1秒前
顾矜的应助被小李采纳,获得10
1秒前
林登万完成签到,获得积分10
1秒前
1秒前
2秒前
ee发布了新的文献求助10
2秒前
2秒前
蔺小兵发布了新的文献求助10
3秒前
荷序完成签到,获得积分20
3秒前
Kiphank发布了新的文献求助10
3秒前
3秒前
ZhuoC完成签到,获得积分10
3秒前
zoiaii发布了新的文献求助10
3秒前
sunny发布了新的文献求助10
4秒前
as发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
潇笑发布了新的文献求助10
5秒前
Nancy发布了新的文献求助20
5秒前
炙热的芙完成签到,获得积分10
5秒前
5秒前
5秒前
5秒前
6秒前
6秒前
7秒前
ding的应助被白晨采纳,获得10
7秒前
英俊糖豆发布了新的文献求助10
7秒前
质量里的光完成签到,获得积分10
7秒前
8秒前
挚友发布了新的文献求助10
8秒前
8秒前
Pepsi发布了新的文献求助10
8秒前
orange_hua发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170142
求助须知:如何正确求助?哪些是违规求助? 9563136
关于积分的说明 21768635
捐赠科研通 7761603
什么是DOI,文献DOI怎么找? 3430600
关于科研通互助平台的介绍 2554420
邀请新用户注册赠送积分活动 2475330